SalvorHardin wrote:Excellent first quarter results announced today. Completely overshadowed by Biden demanding that Moderna loses all patent protection for its vaccine.
Company forecasts $20 earnings per share for 2021, putting the shares on a PE of 8. I reckon that based on advanced vaccine sales of $19.2 billion we could be looking at eps of $25 to $28 per share.
Help me out here, so does Biden demanding that Moderna loses all patent protection for its vaccine have to share their research and secret formulas etc.?
If so can they, MRNA, object and if necessary sue anyone they find in breach of any of their patents?